361 related articles for article (PubMed ID: 2783325)
1. Idiotype variants emerging after anti-idiotype monoclonal antibody therapy of a murine B cell lymphoma.
Weiner GJ; Kaminski MS
J Immunol; 1989 Jan; 142(1):343-51. PubMed ID: 2783325
[TBL] [Abstract][Full Text] [Related]
2. Anti-idiotypic antibodies recognizing stable epitopes limit the emergence of idiotype variants in a murine B cell lymphoma.
Weiner GJ; Kaminski MS
J Immunol; 1990 Mar; 144(6):2436-45. PubMed ID: 1690244
[TBL] [Abstract][Full Text] [Related]
3. Heterogeneity of a murine B cell lymphoma. Isolation and characterization of idiotypic variants.
Starnes CO; Carroll WL; Campbell MJ; Houston LL; Apell G; Levy R
J Immunol; 1988 Jul; 141(1):333-9. PubMed ID: 3132505
[TBL] [Abstract][Full Text] [Related]
4. Bispecific anti-idiotype/anti-CD3 antibody therapy of murine B cell lymphoma.
Weiner GJ; Hillstrom JR
J Immunol; 1991 Dec; 147(11):4035-44. PubMed ID: 1834746
[TBL] [Abstract][Full Text] [Related]
5. Importance of antibody isotype in monoclonal anti-idiotype therapy of a murine B cell lymphoma. A study of hybridoma class switch variants.
Kaminski MS; Kitamura K; Maloney DG; Campbell MJ; Levy R
J Immunol; 1986 Feb; 136(3):1123-30. PubMed ID: 3484499
[TBL] [Abstract][Full Text] [Related]
6. Molecular characterization of anti-idiotype antibody-resistant variants of a murine B cell lymphoma.
Roth MS; Weiner GJ; Allen EA; Terry VH; Harnden CE; Boehnke M; Kaminski MS; Ginsburg D
J Immunol; 1990 Jul; 145(2):768-77. PubMed ID: 2114449
[TBL] [Abstract][Full Text] [Related]
7. Strategies for production of monoclonal anti-idiotype antibodies against human B cell lymphomas.
Thielemans K; Maloney DG; Meeker T; Fujimoto J; Doss C; Warnke RA; Bindl J; Gralow J; Miller RA; Levy R
J Immunol; 1984 Jul; 133(1):495-501. PubMed ID: 6609992
[TBL] [Abstract][Full Text] [Related]
8. Properties of anti-idiotypic T cell lines propagated with syngeneic B lymphocytes. I. T cells bind intact idiotypes and discriminate between the somatic idiotypic variants in a manner similar to the anti-idiotopic antibodies.
Cerny J; Smith JS; Webb C; Tucker PW
J Immunol; 1988 Dec; 141(11):3718-25. PubMed ID: 3263431
[TBL] [Abstract][Full Text] [Related]
9. Idiotypic variation in a human B lymphoma cell line.
Berinstein N; Campbell MJ; Lam K; Carswell C; Levy S; Levy R
J Immunol; 1990 Jan; 144(2):752-8. PubMed ID: 2295809
[TBL] [Abstract][Full Text] [Related]
10. Growth inhibition of a B cell leukemia: evidence implicating an anti-idiotype immune response for protective tumor immunity.
Ciavarra RP; Vitetta ES; Forman J
J Immunol; 1986 Aug; 137(4):1371-5. PubMed ID: 2426362
[TBL] [Abstract][Full Text] [Related]
11. Emergence of idiotype variants during treatment of B-cell lymphoma with anti-idiotype antibodies.
Meeker T; Lowder J; Cleary ML; Stewart S; Warnke R; Sklar J; Levy R
N Engl J Med; 1985 Jun; 312(26):1658-65. PubMed ID: 3923352
[TBL] [Abstract][Full Text] [Related]
12. Idiotype vaccination leads to the emergence of a stable surface Ig-negative variant of the mouse lymphoma BCL1, with different growth characteristics.
George AJ; Spellerberg MB; Stevenson FK
J Immunol; 1988 Mar; 140(5):1695-701. PubMed ID: 3162250
[TBL] [Abstract][Full Text] [Related]
13. Specific enhancement of the therapeutic effect of anti-idiotype antibodies on a murine B cell lymphoma by IL-2.
Berinstein N; Starnes CO; Levy R
J Immunol; 1988 Apr; 140(8):2839-45. PubMed ID: 3258621
[TBL] [Abstract][Full Text] [Related]
14. The generation of monoclonal anti-idiotype antibodies to human B cell-derived leukemias and lymphomas.
Giardina SL; Schroff RW; Kipps TJ; Woodhouse CS; Abrams PG; Rager HC; Morgan AC; Foon KA
J Immunol; 1985 Jul; 135(1):653-8. PubMed ID: 3873497
[TBL] [Abstract][Full Text] [Related]
15. Anti-idiotypic mechanisms involved in suppression of a mouse B cell lymphoma, BCL1.
George AJ; Tutt AL; Stevenson FK
J Immunol; 1987 Jan; 138(2):628-34. PubMed ID: 3491853
[TBL] [Abstract][Full Text] [Related]
16. Idiotype vaccination against murine B cell lymphoma. Humoral and cellular requirements for the full expression of antitumor immunity.
Campbell MJ; Esserman L; Byars NE; Allison AC; Levy R
J Immunol; 1990 Aug; 145(3):1029-36. PubMed ID: 2373859
[TBL] [Abstract][Full Text] [Related]
17. The use of a monoclonal anti-idiotype antibody to study the biology of a human B cell lymphoma.
Hatzubai A; Maloney DG; Levy R
J Immunol; 1981 Jun; 126(6):2397-402. PubMed ID: 6785351
[TBL] [Abstract][Full Text] [Related]
18. Ig isotype switching in B lymphocytes. Isolation and characterization of clonal variants of the murine Ly-1+ B cell lymphoma, CH12, expressing isotypes other than IgM.
Arnold LW; Grdina TA; Whitmore AC; Haughton G
J Immunol; 1988 Jun; 140(12):4355-63. PubMed ID: 3131432
[TBL] [Abstract][Full Text] [Related]
19. Expression of idiotype on the surface of human B cells producing anti-DNA antibody.
Tamate E; Sasaki T; Muryoi T; Takai O; Otani K; Tada K; Yoshinaga K
J Immunol; 1986 Feb; 136(4):1241-6. PubMed ID: 3484765
[TBL] [Abstract][Full Text] [Related]
20. Regulation of an idiotype+ B cell lymphoma. Effects of antigen and anti-idiotopic antibodies on proliferation and Ig secretion.
Ward RE; McNamara-Ward M; Webb CF; Altman D; Lim PL; Tucker PW; Kohler H
J Immunol; 1988 Jul; 141(1):340-6. PubMed ID: 3259969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]